Literature DB >> 32469700

Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis.

Brayan Jonas Mano-Sousa1, Alessandra Moraes Pedrosa1, Bruna Cristina Alves1, José Carlos Fernandes Galduróz2, Vinícius Silva Belo1, Valéria Ernestânia Chaves1, Joaquim Maurício Duarte-Almeida1.   

Abstract

There are several studies investigating the effects of risperidone on autism, but many of these studies are contradictory or inconclusive. This systematic review and meta-analysis investigated the effects of risperidone on five domains of the Aberrant Behaviour Checklist (ABC) scale on Autism Spectrum Disorder (ASD), as well as weight gain and waist circumference. The protocol for the present systematic review and meta-analysis was registered on the International Prospective Register of Systematic Reviews (PROSPERO). For this study, we analysed articles (2,459), selecting them according to the PICOS strategy (Population, Intervention, Comparison, Outcome, Study design). Although risperidone is effective for the treatment of lethargy and inadequate speech, concerns about the association between weight gain, waist circumference and risperidone require a need for evaluation of the risk-benefit ratio in its use. There was a significant association between weight gain, waist circumference and risperidone. In conclusion, it was possible to suggest the efficacy of risperidone for the treatment of lethargy and inadequate speech. Finally, we emphasize that the risk-benefit in its use should be evaluated (Protocol number CRD42019122316). Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Weight gain; aberrant behavior checklist; autism spectrum disorder; risperidone; systematiczzm321990review; waist circumference

Year:  2021        PMID: 32469700     DOI: 10.2174/1570159X18666200529151741

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  2 in total

1.  Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers.

Authors:  Maria J Arranz; Juliana Salazar; Valentin Bote; Alicia Artigas-Baleri; Alexandre Serra-LLovich; Emma Triviño; Jordi Roige; Carlos Lombardia; Martha Cancino; Marta Hernandez; Marc Cendros; Enric Duran-Tauleria; Natalia Maraver; Amaia Hervas
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

2.  A Pediatric Patient With Autism Spectrum Disorder and Comorbid Compulsive Behaviors Treated With Robot-Assisted Relaxation: A Case Report.

Authors:  Vasiliki Aliki Nikopoulou; Vasiliki Holeva; Paraskevi Tatsiopoulou; Vassilis G Kaburlasos; Athanasios E Evangeliou
Journal:  Cureus       Date:  2022-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.